"Speaker Pelosi's drug pricing plan would siphon $1 trillion or more from biopharmaceutical innovators over the next 10 years. CBO's preliminary estimate found this bill ‘would result in lower spending on research and development and thus reduce the introduction of new drugs.’"
speaker pelosi drug pricing plan would siphon trillion or more from biopharmaceutical innovators over the next years read the ad
the ad suggests that the bill would siphon trillion or more from biopharmaceutical innovators over the next years and reduce the introduction of new drugs
house speaker nancy pelosi s flagship proposal to curb prescription drug prices the lower drug costs now act h
cbo preliminary estimate found this bill would result in lower spending on research and development and thus reduce the introduction of new drugs
that leads to the next issue if pharmaceutical revenues dip would fewer innovative drugs become available
